Table 2.

Incidence rates of GC-related AE.

GC-induced AEFollowup, Yrs, mean (SD)Events, nIncidence rate/1000 person-yrs
Musculoskeletal disorders
  Osteoporosis5.56 (3.61)176928.17
  Osteonecrosis6.11 (3.59)4446.44
  Fractures5.77 (3.60)154823.77
  Myopathy6.25 (3.59)791.12
Gastrointestinal disorders
  Peptic ulcer3.75 (3.32)6251147.84
  Viral hepatitis6.18 (3.61)3054.37
  Pancreatitis6.22 (3.59)2092.98
  Nausea and vomiting5.80 (3.60)151723.18
  Fatty liver6.21 (3.59)2163.08
Ophthalmologic disorders
  Cataract5.69 (3.60)167926.16
  Glaucoma6.13 (3.61)4316.23
Infectious diseases
  Tuberculosis6.09 (3.61)5407.85
  Fungal infection5.38 (3.63)256842.26
  Bacterial infection3.56 (3.81)5489136.42
Cardiovascular disorders
  Dyslipidemia5.62 (3.61)170926.94
  Atherosclerosis6.11 (3.59)5247.60
  Ischemic heart disease6.06 (3.59)6659.72
  Heart failure6.08 (3.60)70110.21
  Hypertension5.41 (3.64)230137.67
Neuropsychiatric disorders
  Psychosis6.24 (3.60)1201.70
  Depression5.89 (3.61)100215.07
  Cerebrovascular5.99 (3.60)94013.90
  Insomnia4.23 (3.57)401978.64
Metabolic/endocrine disorders
  Obesity6.26 (3.59)801.13
  Gout and hyperuricemia5.55 (3.62)186829.81
  Cushingoid syndrome6.22 (3.59)1842.62
  Acne vulgaris5.67 (3.65)144722.62
  • GC: glucocorticoid; AE: adverse event.